Analytical Data
-
基因名
PTK9L
- Application
-
别名
A6-related protein
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6IBS0
-
表达区间
1-349aa
-
分子量
66.4 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PTK9L (also known as PTK9-like) is a member of the protein tyrosine kinase family, which plays a crucial role in various cellular processes, including signal transduction, cell growth, adhesion, and differentiation. Research into PTK9L has gained interest due to its potential involvement in several pathological conditions, including cancer and neurodegenerative diseases. The understanding of PTK9L's function and its molecular mechanisms could provide insights into tumorigenesis and cellular signaling pathways. Additionally, PTK9L has been implicated in supporting cellular responses to stress and promoting survival under adverse conditions, making it a relevant target for therapeutic interventions. Recombinant protein studies of PTK9L enable the exploration of its biochemical properties, interactions with other signaling molecules, and its role in disease mechanisms. This research can also lead to the development of novel pharmacological approaches aimed at modulating its activity, which could prove beneficial in treating diseases where PTK9L is dysregulated. Overall, the investigation of PTK9L recombinant proteins is vital for elucidating their roles in health and disease, paving the way for future biomedical applications.
